159 related articles for article (PubMed ID: 31794652)
1. Clinical value of peripheral blood M2/M1 like monocyte ratio in the diagnosis of breast cancer and the differentiation between benign and malignant breast tumors.
Fadhil M; Abdul-Rasheed O; Al-Naqqash M
Acta Biochim Pol; 2019 Dec; 66(4):437-443. PubMed ID: 31794652
[TBL] [Abstract][Full Text] [Related]
2. Increased circulating M2-like monocytes in patients with breast cancer.
Zhang B; Cao M; He Y; Liu Y; Zhang G; Yang C; Du Y; Xu J; Hu J; Gao F
Tumour Biol; 2017 Jun; 39(6):1010428317711571. PubMed ID: 28639912
[TBL] [Abstract][Full Text] [Related]
3. Altered monocyte differentiation and macrophage polarization patterns in patients with breast cancer.
Hung CH; Chen FM; Lin YC; Tsai ML; Wang SL; Chen YC; Chen YT; Hou MF
BMC Cancer; 2018 Apr; 18(1):366. PubMed ID: 29614988
[TBL] [Abstract][Full Text] [Related]
4. Combination of plasma HA and circulating M2-like monocytes may serve as a diagnostic marker for breast cancer.
Zhang B; Cao M; He Y; Liu Y; Zhang G; Yang C; Du Y; Xu J; Hu J; Gao F
J Cancer; 2017; 8(17):3522-3530. PubMed ID: 29151937
[No Abstract] [Full Text] [Related]
5. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.
Trombetta AC; Soldano S; Contini P; Tomatis V; Ruaro B; Paolino S; Brizzolara R; Montagna P; Sulli A; Pizzorni C; Smith V; Cutolo M
Respir Res; 2018 Sep; 19(1):186. PubMed ID: 30249259
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
Goodale D; Phay C; Brown W; Gray-Statchuk L; Furlong P; Lock M; Chin-Yee I; Keeney M; Allan AL
Cytometry B Clin Cytom; 2009 Mar; 76(2):107-17. PubMed ID: 18727054
[TBL] [Abstract][Full Text] [Related]
7. Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro.
Estko M; Baumgartner S; Urech K; Kunz M; Regueiro U; Heusser P; Weissenstein U
BMC Complement Altern Med; 2015 Apr; 15():130. PubMed ID: 25902944
[TBL] [Abstract][Full Text] [Related]
8. Hemarthrosis in hemophilic mice results in alterations in M1-M2 monocyte/macrophage polarization.
Nieuwenhuizen L; Schutgens RE; Coeleveld K; Mastbergen SC; Roosendaal G; Biesma DH; Lafeber FP
Thromb Res; 2014 Mar; 133(3):390-5. PubMed ID: 24252538
[TBL] [Abstract][Full Text] [Related]
9. Human breast cancer cells educate macrophages toward the M2 activation status.
Sousa S; Brion R; Lintunen M; Kronqvist P; Sandholm J; Mönkkönen J; Kellokumpu-Lehtinen PL; Lauttia S; Tynninen O; Joensuu H; Heymann D; Määttä JA
Breast Cancer Res; 2015 Aug; 17(1):101. PubMed ID: 26243145
[TBL] [Abstract][Full Text] [Related]
10. Monocyte M1/M2 profile is altered in paediatric burn patients with hypertrophic scarring.
Williams H; Suda S; Dervish S; Yap YT; Holland AJA; Medbury HJ
Wound Repair Regen; 2021 Nov; 29(6):996-1005. PubMed ID: 34272902
[TBL] [Abstract][Full Text] [Related]
11. Peripheral cells from patients with systemic sclerosis disease co-expressing M1 and M2 monocyte/macrophage surface markers: Relation to the degree of skin involvement.
Mohamed ME; Gamal RM; El-Mokhtar MA; Hassan AT; Abozaid HSM; Ghandour AM; Abdelmoez A Ismail S; A Yousef H; H El-Hakeim E; S Makarem Y; Abdellatif Awad A
Hum Immunol; 2021 Sep; 82(9):634-639. PubMed ID: 34020830
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic power of circulating micro ribonucleic acid 34a in combination with cancer antigen 15-3 as a potential biomarker of breast cancer.
Raheem AR; Abdul-Rasheed OF; Al-Naqqash MA
Saudi Med J; 2019 Dec; 40(12):1218-1226. PubMed ID: 31828273
[TBL] [Abstract][Full Text] [Related]
13. Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions.
Adams DL; Adams DK; Alpaugh RK; Cristofanilli M; Martin SS; Chumsri S; Tang CM; Marks JR
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1037-42. PubMed ID: 27197300
[TBL] [Abstract][Full Text] [Related]
14. A novel serum metabolome score for breast cancer diagnosis.
Rashed R; Darwish H; Omran M; Belal A; Zahran F
Br J Biomed Sci; 2020 Oct; 77(4):196-201. PubMed ID: 32546046
[TBL] [Abstract][Full Text] [Related]
15. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D
Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
[TBL] [Abstract][Full Text] [Related]
17. Effect of colorectal cancer-derived extracellular vesicles on the immunophenotype and cytokine secretion profile of monocytes and macrophages.
Popēna I; Ābols A; Saulīte L; Pleiko K; Zandberga E; Jēkabsons K; Endzeliņš E; Llorente A; Linē A; Riekstiņa U
Cell Commun Signal; 2018 Apr; 16(1):17. PubMed ID: 29690889
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancer.
Gion M; Mione R; Leon AE; Dittadi R
Clin Chem; 1999 May; 45(5):630-7. PubMed ID: 10222349
[TBL] [Abstract][Full Text] [Related]
19. MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.
Incorvaia L; Badalamenti G; Rini G; Arcara C; Fricano S; Sferrazza C; Di Trapani D; Gebbia N; Leto G
Anticancer Res; 2007; 27(3B):1519-25. PubMed ID: 17595770
[TBL] [Abstract][Full Text] [Related]
20. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
El-Attar NI; Gaefar HA
Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
